Table 1.

Baseline characteristics of participants included in the study.

Characteristic	Healthy controls (N = 337,965)	DLBCL (N = 1,207)	P
Age, years			< 0.001
Median (Q1, Q3)	58.00 (50.00, 63.00)	62.00 (57.00, 66.00)
Gender			< 0.001
Female	182,247.00 (53.92%)	523.00 (43.33%)
Male	155,718.00 (46.08%)	684.00 (56.67%)
Ethnicity			< 0.001
Non-White	19,513.00 (5.77%)	40.00 (3.31%)
White	318,452.00 (94.23%)	1,167.00 (96.69%)
Drinking status			0.113
Current	310,492.00 (91.87%)	1,097.00 (90.89%)
Never	15,300.00 (4.53%)	53.00 (4.39%)
Previous	12,173.00 (3.60%)	57.00 (4.72%)
Smoking status			0.144
Current	35,604.00 (10.53%)	125.00 (10.36%)
Never	186,489.00 (55.18%)	636.00 (52.69%)
Previous	115,872.00 (34.29%)	446.00 (36.95%)
Townsend deprivation index			0.562
Median (Q1, Q3)	−2.15 (-3.65, 0.51)	−2.15 (-3.77, 0.55)
Body Mass Index			0.008
Normal	110,129.00 (32.59%)	352.00 (29.16%)
Obese	80,975.00 (23.96%)	314.00 (26.01%)
Overweight	145,123.00 (42.94%)	540.00 (44.74%)
Underweight	1,738.00 (0.51%)	1.00 (0.08%)
Education			0.001
College	109,972.00 (32.54%)	352.00 (29.16%)
Other levels	166,521.00 (49.27%)	591.00 (48.96%)
Unknown	61,472.00 (18.19%)	264.00 (21.87%)
Physical activity			0.787
Non	125,455.00 (37.12%)	443.00 (36.70%)
Yes	212,510.00 (62.88%)	764.00 (63.30%)
Diabetes			0.115
Yes	6,921.00 (2.05%)	33.00 (2.73%)
No	331,044.00 (97.95%)	1,174.00 (97.27%)
Hypertension			< 0.001
Yes	25,896.00 (7.66%)	138.00 (11.43%)
No	312,069.00 (92.34%)	1,069.00 (88.57%)
Lipid lowering drug			< 0.001
Yes	35,585.00 (10.53%)	177.00 (14.66%)
No	302,380.00 (89.47%)	1,030.00 (85.34%)
Antihypotensive_drugs			< 0.001
Yes	37,333.00 (11.05%)	206.00 (17.07%)
No	300,632.00 (88.95%)	1,001.00 (82.93%)

DLBCL, Diffuse large B-cell lymphoma.